July 28, 2018
Print Friendly, PDF & Email

Amy serves as an advisor to the firm’s management and investment committee in developing strategy and evaluation of investment opportunities. As a Senior Advisor, she has a particular focus on evaluating new investment opportunities in the healthcare and technology industries.

Dr. Abernethy is the Chief Medical Officer, Chief Scientific Officer & Senior Vice President, Oncology at Flatiron Health in New York City. Before joining Flatiron, Amy was professor of medicine at Duke University School of Medicine, and ran the Center for Learning Health Care in the Duke Clinical Research Institute and Duke Cancer Care Research Program in the Duke Cancer Institute. She is an international expert in the development of technology platforms to spur novel advancements in healthcare, including the development of systems by which data and technology can support research and healthcare optimization. Amy maintains a close affiliation with Duke, and is a member of the National Academy of Medicine’s National Cancer Policy Forum.

Board Memberships (Current and Past) 
athenahealth, Inc, current
Corporate Advisement
One Health Company, current
SignalPath, current
Pappas Ventures, current

Ph.D., Flinders University, South Australia
M.D., Duke University School of Medicine
B.A. in Biochemistry, University of Pennsylvania